Abstract Thrombosis is frequently observed in COVID‐19, especially in critically ill patients. Management of such life‐threatening conditions is of high importance in the context of the current pandemic. Herein, we provide a case series of myocardial infarction in the clinical evolution of COVID‐19, emphasizing its importance and implications on the cardiovascular system. Due to proinflammatory state in COVID‐19, myocardial infarction may occur. In addition to its fatal entity, the challenges at the way of acute management of myocardial infarction at the time of COVID‐19 pandemic have worsened the outcome of patients.
All Keywords
【저자키워드】 COVID‐19, thrombosis, SARS‐CoV‐2, myocardial infarction (MI), 【초록키워드】 pandemic, cardiovascular system, outcome, COVID‐19, proinflammatory, management, Myocardial infarction, patients, critically ill patients, clinical evolution, implication, addition, case sery, condition, occur, worsened, 【제목키워드】 outcome, Myocardial infarction, case sery, SARS‐CoV‐2‐infected,
【저자키워드】 COVID‐19, thrombosis, SARS‐CoV‐2, myocardial infarction (MI), 【초록키워드】 pandemic, cardiovascular system, outcome, COVID‐19, proinflammatory, management, Myocardial infarction, patients, critically ill patients, clinical evolution, implication, addition, case sery, condition, occur, worsened, 【제목키워드】 outcome, Myocardial infarction, case sery, SARS‐CoV‐2‐infected,